Project Grant R01GM149686
Award Date
9/21/24
Completion Date
8/31/29
Dollars Obligated
$339K
Federal Agency
National Institute of General Medical Sciences
Federal Grant Program
93.859
Assistance Type
Project Grant
Place of Performance
Nashville, TN 37203, USA
Similar Awards
The National Institute of General Medical Sciences (NIGMS) awarded a $1,557,497 Project Grant (CFDA 93.859 - Biomedical Research and Research Training) to Vanderbilt University on August 1, 2024. The grant will support research into the structural requirements and conformational dynamics of sterol 14α-demethylases (CYP51), a key enzyme family involved in sterol biosynthesis and a major drug target for treating fungal infections. The research aims to gain new mechanistic insights into CYP51...
This federal Project Grant award, provided by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), aims to advance the understanding of how extracellular glucose levels regulate cell mechanics and function. The $350,275 award, spanning July 1, 2025 to June 30, 2030, will support research at the University of New Mexico Health Sciences Center (UNM HSC) to investigate the molecular mechanisms, spatiotemporal dynamics,...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training program (CFDA 93.859), provides $931,844 to Vanderbilt University to conduct research on human cytochrome P450 enzymes. The project aims to address several key questions about the functional roles and mechanisms of these enzymes, which are involved in the oxidation of approximately 95% of chemicals, including many drugs, steroids, and carcinogens. The...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training (CFDA 93.859) federal grant program, is supporting research to determine the optimal dynamics for excess glucose remediation via fibration in the proximal small intestine. The $527,805 award, effective from August 1, 2024 to June 30, 2028, will enable Prairie View A&M University to develop a numerical model to quantify glucose transport,...
This is a Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859). The $396,250 award to Vanderbilt University will support research to define the core biochemical principles underlying the spatial and temporal regulation of biomolecular condensates, using P granules in C. elegans embryogenesis as a model system. The key objectives are to: 1) identify biochemical determinants of P granule...
This Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) provides $323,000.00 to the University of Virginia to conduct research on the potential link between glucose-6-phosphate dehydrogenase (G6PD) deficiency and atherosclerosis development. The research aims to test the hypothesis that G6PD deficiency promotes atherosclerosis, in part through its effects on B cell function and production of protective IgM antibodies against...
This five-year $1.5 million Project Grant from the National Science Foundation's Division of Molecular and Cellular Biosciences will fund computer simulations and modeling of G-proteins, molecular machines, and other biomolecules at the University of Southern California. The grant supports research into understanding the control and mediation of life processes by G-proteins and related complexes, the role of ATP in specialized proteins and energy conversion processes, directional motions of...
This Project Grant award of $466,125.00 from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training (CFDA 93.859) program, supports research to identify and characterize key metabolic control mechanisms. The research aims to: Study the physiological importance of an evolutionarily conserved mechanism by which cells sense pyrimidine levels, using genetically engineered cell and mouse models. This will delineate the role of allosteric...
This federal Project Grant award from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training program (CFDA 93.859), is focused on advancing "chemistry-enabled glycoscience" research. The $342,342 award, effective from July 1, 2025 to June 30, 2030, supports the development and application of innovative chemical tools and techniques to better understand the role of glycosylation (the attachment of sugar molecules to proteins) in...
The National Institute of General Medical Sciences (NIGMS) awarded Vanderbilt University a $395,943 Project Grant under the Biomedical Research and Research Training Program (CFDA 93.859) with a performance period from September 1, 2024 to August 31, 2029. The goal of this research program is to develop new spectroscopic methods capable of providing enhanced insight into protein structure and dynamics within complex environments that impact human health. The key products and services to be...